USFDA successfully completes inspection at Indoco’s API manufacturing facility at Patalganga with zero observations
By
ADMIN
Glenmark Partners with Hengrui for Global Rights to HER2-Targeting ADC Trastuzumab Rezetecan
By
ADMIN
Biocon Opens Its First U.S. Manufacturing Facility in New Jersey to Bolster Access & Supply Resilience
By
ADMIN
